A selection visit was successfully completed to participate in a phase III clinical trial for sublingual immunotherapy of tree pollen allergy for children from 5 to 17 years old.

Our Study Site was invited to participate in clinical trials conducted by the Japanese pharmaceutical company Astellas Pharma

Our Study Site was invited to participate in clinical trials conducted by the international pharmaceutical company Biogen.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen